CD4 and primary cutaneous T-cell non-Hodgkin lymphoma: Considering the possibility that the IL-17A-producing activity of benign CD4 T cells is suppressed by the malignant T cells in CTCL lesions, we next focused on ganglioside GD3, which is highly expressed in malignant cells of solid cancers.